The Economic Times

Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 crore

Marksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a record Rs 213 crore, driven by strong growth in its UK and Europe formulation businesses.